ATELLICA TM IM HEPATITIS A IGM
EL ATELLICA™ IM HEPATITIS A IGM (AHAVM) ESTÁ PREVISTO PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUALITATIVA DE LA RESPUESTA DE LA IGM AL VIRUS DE LA HEPATITIS A (HAV) EN SUERO Y PLASMA HUMANOS (EDTA, HEPARINA DE LITIO Y HEPARINA DE SODIO). EL ATE
ATELLICA™ IM HEPATITIS A IGM (AHAVM) IS INTENDED FOR IN VITRO DIAGNOSTIC USE IN THE QUALITATIVE DETERMINATION OF IGM RESPONSE TO HEPATITIS A VIRUS (HAV) IN HUMAN SERUM AND PLASMA (EDTA, LITHIUM HEPARIN AND SODIUM HEPARIN). THE ATE
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE LA RESPUESTA DE IGM FRENTE HEPATITIS A
- Trade Name (English)
- ASSAY FOR THE DETERMINATION OF THE RESPONSE OF IGM AGAINST HEPATITIS A
- Analysis ID
- 1420R2018 SSA
- Registration Date
- June 06, 2018
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
Access comprehensive regulatory information for ATELLICA TM IM HEPATITIS A IGM (ATELLICA TM IM HEPATITIS A IGM) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1420R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on June 06, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.